Clinical Information
Scl 70 (topoisomerase 1) is a 100-kD nuclear and nucleolar enzyme. Scl 70 antibodies are considered to be specific for scleroderma (systemic sclerosis) and are found in up to 60% of patients with this connective tissue disease.
Additionally, can you have mild scleroderma?
Localised scleroderma is the mildest form of the condition. It often affects children, but can occur at any age. This type just affects the skin, causing 1 or more hard patches to develop. Internal organs aren’t affected.
Patients with early diffuse cutaneous scleroderma frequently have delayed Raynaud’s, acute onset, many constitutional symptoms, arthralgias, tendon friction rubs, swollen puffy hands, and early diffuse skin thickening. They may have anti–Scl-70 antibody, as well as anti–RNA polymerase III.
Similarly one may ask, can you test positive for SCL 70 and not have scleroderma?
While Scl-70 antibodies are considered to be highly specific to systemic sclerosis (SSc), a number of studies [2,3,4,5] have documented that patients without a clear diagnosis of SSc often consistently test positive for Scl-70 antibodies when testing is done by ELISA or Multiplex testing methods.
Does a positive Scl-70 always mean scleroderma?
A positive test result for Scl 70 antibodies is consistent with a diagnosis of scleroderma.
Is SCL 70 positive in lupus?
Disease activity was estimated retrospectively by the Systemic Lupus Activity Measure (SLAM). Results: Of 128 consecutive SLE patients, 25% were positive for anti-Scl-70 antibody; this antibody activity was cognate in nature.
What can mimic scleroderma?
However, similar features of hard and thick skin can be seen in other conditions which are often referred to as “scleroderma mimics”. These mimics include eosinophilic fasciitis, nephrogenic systemic fibrosis, scleromyxedema, and scleredema among others.
What is considered a positive Scl-70?
Serum anti-topoisomerase, also known as SCL-70, is specific to diffuse scleroderma (and the test is positive in 20% of people with scleroderma). Two-thirds of patients with this antibody have diffuse scleroderma. They also have pulmonary interstitial fibrosis and reduced survival.
What is the difference between Raynaud’s and scleroderma?
Scleroderma is an autoimmune disease that involves the skin, joints, circulation, gastrointestinal tract, kidneys, lungs and heart. Patients with Raynaud’s disease may experience cool/painful fingers or toes due to excessive constriction of blood vessels from cold exposure or stress.
What is the normal range for Scl-70?
The upper limit of normal for the Test-Scl-70 ELISA was established with 50 randomly chosen BBD sera by the percentile ranking method (28) at 32 units/ml, for a disease specificity of 100% (28) (the mean + 3SD was 26 units/ml).
What labs are abnormal with scleroderma?
How is scleroderma diagnosed?
- Blood tests: Elevated levels of immune factors, known as antinuclear antibodies, are found in 95% of patients with scleroderma. …
- Pulmonary function tests: These tests are done to measure how well the lungs are functioning.
What were your first signs of scleroderma?
Symptoms of scleroderma may include:
- Thickening and swelling of the fingers.
- Pale fingers that may become numb and tingle when exposed to cold or stress, known as Raynaud’s phenomenon.
- Joint pain.
- Taut, shiny, darker skin on large areas, which can cause problems with movement.